Liya Liu
International Business Manager at 绿叶制药集团有限公司- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
中文 -
-
English Professional working proficiency
Topline Score
Bio
Experience
-
Luye Pharma Group
-
China
-
Pharmaceutical Manufacturing
-
100 - 200 Employee
-
International Business Manager
-
Dec 2021 - Present
Covid-19 vaccine is available We - Patronus, one of the subsidiary companies of Luye, focuses on the development, manufacturing and commercialization of new technology routes of vaccines and strives to be a pioneer in the industry. For COVID-19 VACCINE, we're organizing clinical trial both aboard and China, Thailand, Pakistan, the Philippines, Laos and others. We also have some other vaccines in pipeline both for human and veterinary use. Covid-19 vaccine is available We - Patronus, one of the subsidiary companies of Luye, focuses on the development, manufacturing and commercialization of new technology routes of vaccines and strives to be a pioneer in the industry. For COVID-19 VACCINE, we're organizing clinical trial both aboard and China, Thailand, Pakistan, the Philippines, Laos and others. We also have some other vaccines in pipeline both for human and veterinary use.
-
-
-
Sihuan Pharmaceutical Holdings Group
-
China
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
International business and registration
-
Nov 2019 - Dec 2021
We're anti-diabetic products manufacturer in Jilin. Our products are insulins, DDP-4, SGLT-2, GLP-1 and others. Insulin product covering long-acting, short-acting and fast acting... like insulin aspart, Insulin degludec, Liraglutide, Janaglifozin-our innovation drug, Dapagliflozin, Acarbose... Now insulin aspart and Janaglifozin finished the clinical trial, and available for international market. We're anti-diabetic products manufacturer in Jilin. Our products are insulins, DDP-4, SGLT-2, GLP-1 and others. Insulin product covering long-acting, short-acting and fast acting... like insulin aspart, Insulin degludec, Liraglutide, Janaglifozin-our innovation drug, Dapagliflozin, Acarbose... Now insulin aspart and Janaglifozin finished the clinical trial, and available for international market.
-
-
-
-
International Business Manager
-
Jan 2009 - Nov 2019
Work Experience2009.1-2013.1Hepatitis A Vaccine DepartmentTogether with the professional company to re-regulate and improve the GMP system.Establish the file system and proceed with the GMP certification.Responsible for the establishment of the department's documents.In early 2013, the department successfully passed the National GMP certification.2013.1-2014.10QA DepartmentOn-site QA of varicella vaccine in charge of deviation, change, CAPA, self-inspection, GMP compliance inspection;Inspection by Wockhardt and successfully passed. 2014.10-2018.10International Business DepartmentInternational inspection and registrationOrganizing CTD dossier, SMF, DMF, SmPC, Schedule D I, D II for registration and re-registration, more than 100 sets as required.Hosted India, Pakistan, Malaysia, Thailand, Philippines and other national inspections and successfully passed.Cooperation with Thailand and Malaysia in vaccine products.Bulk exportComplete the registration of bulk in Bangladesh and lead the technical team to Bangladesh for discussion and guidance.International certificationTogether with the professional WHO qualification guidance team, process the preliminary for WHO qualification.Conduct PIC/s inspection and global CT.
-
-
Education
-
Changchun University of Science and Technology
BEc, International Economics and Trade -
Jilin Agricultural University
学士, Biotechnology